Main Subject - Internet and Businesses Online

Those of you who have had any experience in email marketing know that i

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

t is getting increasingly harder to get your list to open their message

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

s. Email marketing has been abused in the past, and with all of the sp

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

am being sent it is hard to come across as legitimate. Having a relati

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

vely small list that opens 100% of the emails you send would be way mor

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e effective than a huge list that only has a 10% open rate.

Why waste

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

time going through your list and setting up messages to be sent when y

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ou know only 1 in 10 actually reads the email? Subscribers that actual

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ly open your emails on a routinely basis are much more likely to buy a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

new product that you release.

Using an opt in form for your new subscr

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ibers can be a very effective way to weed out the uninterested readers.

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

This is because some people sign up for a mailing list just to get a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

free report, and then ignore the rest of the emails. This brings down

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

your open-rate percentages. If the first email was an opt in that requ

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ired them to click a link to confirm, they would have never been subscr

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ibed in the first place.

The visitors that are truly interested in the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

information you have to offer will opt in to your mailing list and pro

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ve to be much more profitable than the previously mentioned would-be su

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

bscriber. I strongly encourage you to use opt-in mailing lists because

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

it increases list profit per subscriber and decreases spam complaints.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/62248/mainsubjects-Small-Responsive-Lists-are-Better-than-Large-Unresponsive-Lists.html">Small Responsive Lists are Better than Large Unresponsive Lists</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/62248/mainsubjects-Small-Responsive-Lists-are-Better-than-Large-Unresponsive-Lists.html]Small Responsive Lists are Better than Large Unresponsive Lists[/url]

I suspect that everyone has an idea of what lamination is even if you have only seen it in passing. Restaurant menus are a common example. A plastic finish is placed over the menu to protect it from food and stains.

Just getting started or wondering why your resume isn't getting any results? There are a number of pitfalls you may accidentally encounter. Here is some practical advice on what to do and what not to do.

So much has been written about the value of networking, but mainly from the perspective of the jobseeker. This article provides useful tips to jobseekers and currently employed alike to help them attain a greater sense of satisfaction.

Tags

Links

Main Subject - Small Responsive Lists are Better than Large Unresponsive Lists

Related Articles: